Hummingbird Bioscience was founded in 2014 to develop better ways of generating novel therapeutic antibody-based drugs. Using rational, systems biology approaches the aim of the company is to generate therapeutic antibodies which can be deployed in precision medicine.To further this goal the company is utilizing cutting edge single cell profiling coupled with expertise in high throughput sequencing, bioinformatics and structural biology to enable our drugs to be used in the right patient at the right time.The company has 20 employees with operations in JLABS Houston, South San Francisco, and also in Singapore.
Hummingbird Bioscience was founded in 2014 to develop better ways of generating novel therapeutic antibody-based drugs. Using rational, systems biology approaches the aim of the company is to generate therapeutic antibodies which can be deployed in precision medicine.To further this goal the company is utilizing cutting edge single cell profiling coupled with expertise in high throughput sequencing, bioinformatics and structural biology to enable our drugs to be used in the right patient at the right time.The company has 20 employees with operations in JLABS Houston, South San Francisco, and also in Singapore.
Hummingbird Bioscience was founded in 2014 to develop better ways of generating novel therapeutic antibody-based drugs. Using rational, systems biology approaches the aim of the company is to generate therapeutic antibodies which can be deployed in precision medicine.To further this goal the company is utilizing cutting edge single cell profiling coupled with expertise in high throughput sequencing, bioinformatics and structural biology to enable our drugs to be used in the right patient at the right time.The company has 20 employees with operations in JLABS Houston, South San Francisco, and also in Singapore.